These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Estrogen-anchored pH-sensitive liposomes as nanomodule designed for site-specific delivery of doxorubicin in breast cancer therapy. Paliwal SR; Paliwal R; Pal HC; Saxena AK; Sharma PR; Gupta PN; Agrawal GP; Vyas SP Mol Pharm; 2012 Jan; 9(1):176-86. PubMed ID: 22091702 [TBL] [Abstract][Full Text] [Related]
3. Redox-sensitive and hyaluronic acid functionalized liposomes for cytoplasmic drug delivery to osteosarcoma in animal models. Chi Y; Yin X; Sun K; Feng S; Liu J; Chen D; Guo C; Wu Z J Control Release; 2017 Sep; 261():113-125. PubMed ID: 28666726 [TBL] [Abstract][Full Text] [Related]
4. Reversibly crosslinked hyaluronic acid nanoparticles for active targeting and intelligent delivery of doxorubicin to drug resistant CD44+ human breast tumor xenografts. Zhong Y; Zhang J; Cheng R; Deng C; Meng F; Xie F; Zhong Z J Control Release; 2015 May; 205():144-54. PubMed ID: 25596560 [TBL] [Abstract][Full Text] [Related]
5. Self-assembled pH-responsive hyaluronic acid-g-poly((L)-histidine) copolymer micelles for targeted intracellular delivery of doxorubicin. Qiu L; Li Z; Qiao M; Long M; Wang M; Zhang X; Tian C; Chen D Acta Biomater; 2014 May; 10(5):2024-35. PubMed ID: 24365705 [TBL] [Abstract][Full Text] [Related]
6. The intracellular drug delivery and anti tumor activity of doxorubicin loaded poly(gamma-benzyl L-glutamate)-b-hyaluronan polymersomes. Upadhyay KK; Bhatt AN; Mishra AK; Dwarakanath BS; Jain S; Schatz C; Le Meins JF; Farooque A; Chandraiah G; Jain AK; Misra A; Lecommandoux S Biomaterials; 2010 Apr; 31(10):2882-92. PubMed ID: 20053435 [TBL] [Abstract][Full Text] [Related]
7. Phytosterol-loaded CD44 receptor-targeted PEGylated nano-hybrid phyto-liposomes for synergistic chemotherapy. Gautam M; Thapa RK; Gupta B; Soe ZC; Ou W; Poudel K; Jin SG; Choi HG; Yong CS; Kim JO Expert Opin Drug Deliv; 2020 Mar; 17(3):423-434. PubMed ID: 32028805 [No Abstract] [Full Text] [Related]
8. Hyaluronic acid derivative-coated nanohybrid liposomes for cancer imaging and drug delivery. Park JH; Cho HJ; Yoon HY; Yoon IS; Ko SH; Shim JS; Cho JH; Park JH; Kim K; Kwon IC; Kim DD J Control Release; 2014 Jan; 174():98-108. PubMed ID: 24280260 [TBL] [Abstract][Full Text] [Related]
9. The effect of dual-functional hyaluronic acid-vitamin E succinate micelles on targeting delivery of doxorubicin. Wang J; Ma W; Guo Q; Li Y; Hu Z; Zhu Z; Wang X; Zhao Y; Chai X; Tu P Int J Nanomedicine; 2016; 11():5851-5870. PubMed ID: 27853369 [TBL] [Abstract][Full Text] [Related]
10. Lipoic acid-derived cross-linked liposomes for reduction-responsive delivery of anticancer drug. Ling L; Ismail M; Du Y; Yao C; Li X Int J Pharm; 2019 Apr; 560():246-260. PubMed ID: 30769133 [TBL] [Abstract][Full Text] [Related]
11. Hyaluronic Acid-Based pH-Sensitive Polymer-Modified Liposomes for Cell-Specific Intracellular Drug Delivery Systems. Miyazaki M; Yuba E; Hayashi H; Harada A; Kono K Bioconjug Chem; 2018 Jan; 29(1):44-55. PubMed ID: 29183110 [TBL] [Abstract][Full Text] [Related]
12. Dual-functional liposomes based on pH-responsive cell-penetrating peptide and hyaluronic acid for tumor-targeted anticancer drug delivery. Jiang T; Zhang Z; Zhang Y; Lv H; Zhou J; Li C; Hou L; Zhang Q Biomaterials; 2012 Dec; 33(36):9246-58. PubMed ID: 23031530 [TBL] [Abstract][Full Text] [Related]
13. A novel cancer targeting approach based on estrone anchored stealth liposome for site-specific breast cancer therapy. Paliwal SR; Paliwal R; Mishra N; Mehta A; Vyas SP Curr Cancer Drug Targets; 2010 May; 10(3):343-53. PubMed ID: 20370682 [TBL] [Abstract][Full Text] [Related]
14. Targeted delivery of doxorubicin using stealth liposomes modified with transferrin. Li X; Ding L; Xu Y; Wang Y; Ping Q Int J Pharm; 2009 May; 373(1-2):116-23. PubMed ID: 19429296 [TBL] [Abstract][Full Text] [Related]
15. pH-Responsive Hyaluronic Acid-Based Mixed Micelles for the Hepatoma-Targeting Delivery of Doxorubicin. Wu JL; Tian GX; Yu WJ; Jia GT; Sun TY; Gao ZQ Int J Mol Sci; 2016 Mar; 17(4):364. PubMed ID: 27043540 [TBL] [Abstract][Full Text] [Related]
16. A novel redox-sensitive system based on single-walled carbon nanotubes for chemo-photothermal therapy and magnetic resonance imaging. Hou L; Yang X; Ren J; Wang Y; Zhang H; Feng Q; Shi Y; Shan X; Yuan Y; Zhang Z Int J Nanomedicine; 2016; 11():607-24. PubMed ID: 26917960 [TBL] [Abstract][Full Text] [Related]
17. Liposome-encapsulated doxorubicin targeted to CD44: a strategy to kill CD44-overexpressing tumor cells. Eliaz RE; Szoka FC Cancer Res; 2001 Mar; 61(6):2592-601. PubMed ID: 11289136 [TBL] [Abstract][Full Text] [Related]
18. Hyaluronic acid-capped compact silica-supported mesoporous titania nanoparticles for ligand-directed delivery of doxorubicin. Gupta B; Poudel BK; Ruttala HB; Regmi S; Pathak S; Gautam M; Jin SG; Jeong JH; Choi HG; Ku SK; Yong CS; Kim JO Acta Biomater; 2018 Oct; 80():364-377. PubMed ID: 30201431 [TBL] [Abstract][Full Text] [Related]
19. Hyaluronic acid nanogels prepared via ortho ester linkages show pH-triggered behavior, enhanced penetration and antitumor efficacy in 3-D tumor spheroids. Yang G; Fu S; Yao W; Wang X; Zha Q; Tang R J Colloid Interface Sci; 2017 Oct; 504():25-38. PubMed ID: 28527297 [TBL] [Abstract][Full Text] [Related]
20. Hyaluronic acid-decorated graphene oxide nanohybrids as nanocarriers for targeted and pH-responsive anticancer drug delivery. Song E; Han W; Li C; Cheng D; Li L; Liu L; Zhu G; Song Y; Tan W ACS Appl Mater Interfaces; 2014 Aug; 6(15):11882-90. PubMed ID: 25000539 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]